1. Auflage 2021,
Band: 1303, 409 Seiten, Gebunden, HC runder Rücken kaschiert, Format (B × H): 178 mm x 254 mm, Gewicht: 998 g
Reihe: Advances in Experimental Medicine and Biology
Verlag: Springer, Berlin
Wang Lung Inflammation in Health and Disease, Volume I
Current treatment options for lung disease are neither effective, nor condition-specific; there is a desperate need for novel therapeutics in the field. Additionally, the molecular and physiological significance of most major lung diseases is not well understood, which further impedes development of new treatments, especially in the case of coexistent lung diseases with other inflammatory diseases. Great progress has been made in recent years in many areas of the field, particularly in understanding the molecular geneses, regulatory mechanisms, signalling pathways, and cellular processes within lung disease, as well as basic and clinical technology, drug discovery, diagnoses, treatment options, and predictive prognoses.
This is the first text to aggregate these developments. In two comprehensive volumes, experts from all over the world present state-of-the-art advances in the study of lung inflammation in health and disease. Contributing authors cover well-known as well as emerging topics in basic, translational, and clinical research, with the aim of providing researchers, clinicians, professionals, and students with new perspectives and concepts. The editors hope these books will also help to direct future research in lung disease and other inflammatory diseases, and result in the development of novel therapeutics.
Weitere Infos & Material
1. Potential role of mast cells in regulating corticosteroid insensitivity in severe asthma2. Galectin-3 Promotes ROS, Inflammation and Vascular Fibrosis in Pulmonary Arterial Hypertension3. Anti-Inflammatory Effects of Statins in Lung Vascular Pathology: From Basic Science to Clinical Trials4. Evolving Schema for Employing Network Biology Approaches to Understand Pulmonary Hypertension5. Pulmonary Inflammation and KRAS Mutation in Lung Cancer6. microRNA Targets for Asthma Therapy7. Roles of genetic predisposition in the sex-bias of pulmonary pathophysiology, as a function of estrogens8. Hypercapnic respiratory failure-driven skeletal muscle dysfunction: It is time for animal mod-els-based mechanistic research9. Role of airway smooth muscle in inflammation related to asthma and COPDHiroaki Kume10. Systemic Sclerosis and Pulmonary Disease11. Innate Lymphoid Cells in airway inflammation12. Sjogren's Syndrome and pulmonary disease13. Redox Regulation, Oxidative Stress and Inflammation in Group 3 Pulmonary Hypertension14. Sex-Steroid Signaling in Lung Diseases and Inflammation15. Cytokines, Chemokines and Inflammation in Pulmonary Arterial Hypertension16. Interactive roles of CaMKII/Ryanodine Receptor Signaling and Inflammation in Lung Diseases17. Reciprocal Correlations of Inflammatory and Calcium Signaling in Asthma Pathogenesis18. Crosstalk between Lung and Extrapulmonary Organs in Infection and Inflammation19. Inflammation in Pulmonary Arterial Hypertension20. Lysophospholids in Lung Inflammatory Diseases